Literature DB >> 7629743

Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.

D Bazile1, C Prud'homme, M T Bassoullet, M Marlard, G Spenlehauer, M Veillard.   

Abstract

Nanoparticles were prepared from methoxy poly(ethylene glycol)poly(d,l-lactic acid) block copolymers (Me.PEG-PLA) or blends of Me.PEG-PLA and PLA by the precipitation-solvent diffusion method. These nanoparticles, labeled by introducing [14C]PLA in the formulation, were shown to be more slowly captured by cultured THP-1 monocytes than F68-coated PLA nanoparticles, in a PEG chain-length-dependent manner. In vivo, the half-life in plasma of the Me.PEG-PLA nanoparticles that were intravenously administered to rats is increased by a factor 180 compared with the F68-coated PLA nanoparticles. This mononuclear phagocytes system avoidance was explained according to a conformation model in which the PEG density at the surface of the particles is a key parameter.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629743     DOI: 10.1002/jps.2600840420

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  101 in total

1.  Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine.

Authors:  José das Neves; Johan Michiels; Kevin K Ariën; Guido Vanham; Mansoor Amiji; Maria Fernanda Bahia; Bruno Sarmento
Journal:  Pharm Res       Date:  2011-11-10       Impact factor: 4.200

Review 2.  Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer.

Authors:  Liangqian Tong; Ming Zhao; Shu Zhu; Jing Chen
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

Review 3.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 4.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

Review 5.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

6.  Studies of the cellular uptake of hydrogel nanospheres and microspheres by phagocytes, vascular endothelial cells, and smooth muscle cells.

Authors:  Kytai Truong Nguyen; Kajal P Shukla; Miriam Moctezuma; Arthur R C Braden; Jun Zhou; Zhibing Hu; Liping Tang
Journal:  J Biomed Mater Res A       Date:  2009-03-15       Impact factor: 4.396

Review 7.  Delivery materials for siRNA therapeutics.

Authors:  Rosemary Kanasty; Joseph Robert Dorkin; Arturo Vegas; Daniel Anderson
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

8.  Nano-encapsulation of plitidepsin: in vivo pharmacokinetics, biodistribution, and efficacy in a renal xenograft tumor model.

Authors:  Hugo Oliveira; Julie Thevenot; Elisabeth Garanger; Emmanuel Ibarboure; Pilar Calvo; Pablo Aviles; Maria Jose Guillen; Sébastien Lecommandoux
Journal:  Pharm Res       Date:  2013-11-28       Impact factor: 4.200

9.  Synthesis of pegylated immunonanoparticles.

Authors:  Jean-Christophe Olivier; Ramon Huertas; Hwa Jeong Lee; Frederic Calon; William M Pardridge
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

10.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

Authors:  Rajiv Kumar; Indrajit Roy; Tymish Y Ohulchanskky; Lisa A Vathy; Earl J Bergey; Munawwar Sajjad; Paras N Prasad
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.